Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias

Stuart J Thomas, George T GrossbergDepartment of Neurology and Psychiatry, Saint Louis University School of Medicine, St. Louis, MO, USAAbstract: Memantine is an uncompetitive N-methyl-D-aspartate receptor antagonist with moderate affinity. Its mechanism of action is neuroprotective and potentially...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Stuart J Thomas, George T Grossberg
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2009
Materias:
Acceso en línea:https://doaj.org/article/bc527f5f182d4d8da9d54a0b10ad2a1e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bc527f5f182d4d8da9d54a0b10ad2a1e
record_format dspace
spelling oai:doaj.org-article:bc527f5f182d4d8da9d54a0b10ad2a1e2021-12-02T00:35:49ZMemantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias1178-1998https://doaj.org/article/bc527f5f182d4d8da9d54a0b10ad2a1e2009-09-01T00:00:00Zhttps://www.dovepress.com/memantine-a-review-of-studies-into-its-safety-and-efficacy-in-treating-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Stuart J Thomas, George T GrossbergDepartment of Neurology and Psychiatry, Saint Louis University School of Medicine, St. Louis, MO, USAAbstract: Memantine is an uncompetitive N-methyl-D-aspartate receptor antagonist with moderate affinity. Its mechanism of action is neuroprotective and potentially therapeutic in several neuropsychiatric diseases. It has been approved by the FDA for the treatment of moderate to severe Alzheimer’s disease (AD) either as a monotherapy or in combination with cholinesterase inhibitors. This review covers key studies of memantine’s safety and efficacy in treating moderate to severe AD. It also covers current research into other dementias including but not exclusively mild AD and vascular dementia. Other studies on the efficacy of memantine for other neuropsychiatric diseases are discussed. Memantine is a safe and effective drug that merits further research on several topics. Clinicians should be aware of new studies and potential uses of memantine because of its safety and efficacy.Keywords: memantine, Alzheimer’s disease, dementiaStuart J ThomasGeorge T GrossbergDove Medical PressarticleMemantineAlzheimer's diseaseDementiaReviewGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 4, Pp 367-377 (2009)
institution DOAJ
collection DOAJ
language EN
topic Memantine
Alzheimer's disease
Dementia
Review
Geriatrics
RC952-954.6
spellingShingle Memantine
Alzheimer's disease
Dementia
Review
Geriatrics
RC952-954.6
Stuart J Thomas
George T Grossberg
Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias
description Stuart J Thomas, George T GrossbergDepartment of Neurology and Psychiatry, Saint Louis University School of Medicine, St. Louis, MO, USAAbstract: Memantine is an uncompetitive N-methyl-D-aspartate receptor antagonist with moderate affinity. Its mechanism of action is neuroprotective and potentially therapeutic in several neuropsychiatric diseases. It has been approved by the FDA for the treatment of moderate to severe Alzheimer’s disease (AD) either as a monotherapy or in combination with cholinesterase inhibitors. This review covers key studies of memantine’s safety and efficacy in treating moderate to severe AD. It also covers current research into other dementias including but not exclusively mild AD and vascular dementia. Other studies on the efficacy of memantine for other neuropsychiatric diseases are discussed. Memantine is a safe and effective drug that merits further research on several topics. Clinicians should be aware of new studies and potential uses of memantine because of its safety and efficacy.Keywords: memantine, Alzheimer’s disease, dementia
format article
author Stuart J Thomas
George T Grossberg
author_facet Stuart J Thomas
George T Grossberg
author_sort Stuart J Thomas
title Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias
title_short Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias
title_full Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias
title_fullStr Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias
title_full_unstemmed Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias
title_sort memantine: a review of studies into its safety and efficacy in treating alzheimer’s disease and other dementias
publisher Dove Medical Press
publishDate 2009
url https://doaj.org/article/bc527f5f182d4d8da9d54a0b10ad2a1e
work_keys_str_mv AT stuartjthomas memantineareviewofstudiesintoitssafetyandefficacyintreatingalzheimerrsquosdiseaseandotherdementias
AT georgetgrossberg memantineareviewofstudiesintoitssafetyandefficacyintreatingalzheimerrsquosdiseaseandotherdementias
_version_ 1718403643909079040